Our Bond Secures $250K ARR Deal with $300B Pharmaceutical Leader
Our Bond secured a $250,000 annual recurring revenue contract with a Top-5 global pharmaceutical company (>$300 billion market cap), covering 5,000 of its 100,000 employees with 24/7 AI-powered security. The phase 1 deal includes an expansion pathway that could boost cumulative contract value beyond $1 million.
1. Phase 1 Agreement Details
Our Bond executed a phase 1 commercial agreement valued at $250,000 in annual recurring revenue with one of the world’s five largest pharmaceutical firms, which has a market capitalization exceeding $300 billion. The contract covers 5,000 of the customer’s 100,000 employees across multiple U.S. locations under a 24/7 AI-powered personal security model.
2. ARR Growth and Expansion Potential
This initial engagement establishes a new recurring revenue stream for Our Bond and serves as a foundation for phased expansion. The agreement includes provisions for scope increases that could elevate the total contract value beyond $1 million, supporting the company’s strategy to drive scalable ARR growth within large enterprises.
3. Platform Versatility and Market Opportunity
Bond’s AI-powered Preventative Personal Security platform is designed to protect diverse employee populations—from executives to field staff—across global geographies and operating conditions. The company highlights continued enterprise momentum and positions this contract as a step toward making its platform a global standard of care for workforce security.